Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia.
Carella AM, Garuti A, Cirmena G, Catania G, Rocco I, Palermo C, Pica G, Pierri I, Miglino M, Ballestrero A, Gobbi M, Patrone F. Carella AM, et al. Among authors: ballestrero a. Leuk Lymphoma. 2010 Feb;51(2):275-8. doi: 10.3109/10428190903503446. Leuk Lymphoma. 2010. PMID: 20038234
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Cea M, Cirmena G, Garuti A, Rocco I, Palermo C, Cagnetta A, Moran E, Colombo N, Grasso R, Fugazza G, Gobbi M, Nencioni A, Ballestrero A, Patrone F. Cea M, et al. Among authors: ballestrero a. Leuk Res. 2010 Sep;34(9):e240-2. doi: 10.1016/j.leukres.2010.03.036. Epub 2010 May 5. Leuk Res. 2010. PMID: 20447687 No abstract available.
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
Ballestrero A, Cirmena G, Dominietto A, Garuti A, Rocco I, Cea M, Moran E, Nencioni A, Miglino M, Raiola AM, Bacigalupo A, Patrone F. Ballestrero A, et al. Int J Lab Hematol. 2010 Aug 1;32(4):387-91. doi: 10.1111/j.1751-553X.2009.01198.x. Epub 2009 Nov 30. Int J Lab Hematol. 2010. PMID: 19968720
Proteasome inhibitors: antitumor effects and beyond.
Nencioni A, Grünebach F, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: ballestrero a. Leukemia. 2007 Jan;21(1):30-6. doi: 10.1038/sj.leu.2404444. Epub 2006 Nov 9. Leukemia. 2007. PMID: 17096016 Review.
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.
Garuti A, Rocco I, Cirmena G, Chiaramondia M, Baccini P, Calabrese M, Palermo C, Friedman D, Zoppoli G, Ballestrero A. Garuti A, et al. Among authors: ballestrero a. Gynecol Oncol. 2014 Feb;132(2):389-96. doi: 10.1016/j.ygyno.2013.11.020. Epub 2013 Nov 21. Gynecol Oncol. 2014. PMID: 24269902
213 results